Medicare AdvantageCoverageMedium impact
MA11.079e, Evaluation and Treatment of Erectile Dysfunction (ED)
Independence Blue Cross·Urology, Internal Medicine, Family Medicine +1 more·Medical Policy
Effective date
Jan 21, 2026
We identified it
Jun 19, 2026
Summary
Policy MA11.079e regarding evaluation and treatment of erectile dysfunction was reissued effective January 21, 2026. Without access to the full policy text, the specific changes cannot be determined from the provided information. The billing team must review the complete policy document to identify any new prior authorization requirements, covered/non-covered services, billing code updates, or documentation changes that may affect ED-related claims processing.
Action Required
By January 21, 2026: Billing team must obtain and review the complete MA11.079e policy from https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=01&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#medicare-advantage-ma11-079e-evaluation-and-treatment-of-ere. Identify all specific billing codes, prior authorization requirements, coverage limitations, and documentation requirements. Update billing software, encounter forms, and provider guidelines accordingly. Notify providers of any changes to ED evaluation and treatment coverage or billing procedures. Failure to comply may result in claim denials or rejections for Medicare Advantage members.